Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v7-EN
Language French English
Date Updated 2021-01-28 2021-01-14
Drug Identification Number 02394898 02394898
Brand name ACT ANASTROZOLE ACT ANASTROZOLE
Common or Proper name ANASTROZOLE 1MG FC TAB ANASTROZOLE 1MG FC TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ANASTROZOLE ANASTROZOLE
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30UD 30UD
ATC code L02BG L02BG
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-22 2020-01-22
Estimated end date Unknown
Actual end date 2021-01-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments